| Fri, 18 Jan 2019 18:59:42: | ALS researchers at Harvard uncover new biomarker and drug target
|
| Fri, 18 Jan 2019 13:25:25: | Celgene strikes Obsidian deal to boost CAR-T options
|
| Fri, 18 Jan 2019 12:29:09: | Former Insmed CMO Streck resurfaces at Alder
|
| Fri, 18 Jan 2019 07:57:53: | Novartis allies with Oxford academics for big data R&D drive
|
| Thu, 17 Jan 2019 19:11:20: | Chutes & Ladders—Exoduses continue at AstraZeneca
|
| Thu, 17 Jan 2019 16:57:03: | Apple, J&J to put the Apple Watch’s ECG through large-scale clinical testing
|
| Thu, 17 Jan 2019 14:20:50: | Gilead’s clinical research VP moves to U.S.-China NASH startup Terns Pharma
|
| Thu, 17 Jan 2019 13:53:24: | Lipocine talks up interim data from small NASH study
|
| Thu, 17 Jan 2019 13:04:59: | It's a case of déjà vu as Alzheon pulls IPO again
|
| Thu, 17 Jan 2019 11:36:16: | Could a safer version of an old blood pressure drug be repurposed in multiple sclerosis?
|
| Thu, 17 Jan 2019 11:22:18: | Aptinyx fails phase 2 pain test, sparking stock crash
|
| Wed, 16 Jan 2019 13:59:39: | Five Prime cuts 41 jobs, narrows focus to clinical-stage drugs
|
| Wed, 16 Jan 2019 13:32:25: | Life Biosciences raises $50M as longevity race heats up
|
| Wed, 16 Jan 2019 11:08:58: | Anti-aging startup Juvenescence bags $46M for pipeline push
|
| Wed, 16 Jan 2019 09:41:31: | NIH’s stem cell-based AMD therapy set for first human trial
|
| Tue, 15 Jan 2019 19:41:34: | FDA planning new guidance, hires in cell and gene therapies for 2019
|
| Tue, 15 Jan 2019 14:37:01: | Seres elevates CFO Eric Shaff to CEO post as it advances immunology therapies
|
| Tue, 15 Jan 2019 13:52:27: | As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations
|
| Tue, 15 Jan 2019 13:34:04: | Attendees fed up with venue, high prices call to move JPM out of San Francisco
|
| Tue, 15 Jan 2019 13:01:44: | Aimmune says shutdown blocks peanut allergy drug review
|
| Tue, 15 Jan 2019 12:25:00: | Roche R&D executive begins a new voyage with biotech move
|
| Tue, 15 Jan 2019 09:53:30: | Another AstraZeneca executive hits the exit, joins alumnus at Immunocore
|
| Tue, 15 Jan 2019 09:15:53: | Insmed CMO out the door, headed for 'West Coast'
|
| Mon, 14 Jan 2019 14:26:01: | Sean Bohen to leave AstraZeneca as exodus continues
|
| Mon, 14 Jan 2019 13:54:47: | Verona tanks after COPD drug misses phase 2 endpoint
|
